Absence of acute effects of angiotensin II on atrial electrophysiology in humans

In differing animal models, angiotensin-converting enzyme inhibition or angiotensin II (AII) antagonists has been shown to prevent both acute (hours) (2) electrical remodeling and chronic (weeks) structural remodeling (3). Clinical studies have suggested that AII antagonists or angiotensin-convertin...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2005-01, Vol.45 (1), p.154-156
Main Authors: Kistler, Peter M., Davidson, Neil C., Sanders, Prashanthan, Fynn, Simon P., Stevenson, Irene H., Spence, Steven J., Vohra, Jitendra K., Sparks, Paul B., Kalman, Jonathan M.
Format: Article
Language:English
Subjects:
Adult
Angiotensin II - pharmacology
Atrial Function - drug effects
Atrial Function - physiology
Cardiology
Drug therapy
Electrophysiologic Techniques, Cardiac
Enzymes
Female
Heart Atria - drug effects
Heart failure
Hemodynamics - drug effects
Humans
Male
Renin-Angiotensin System - physiology
Vasoconstrictor Agents - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c448t-d11571b0f6aaed25b904ecb5f694e81c90740dd6223b0fbc77f1d0c1f75fa6003
cites cdi_FETCH-LOGICAL-c448t-d11571b0f6aaed25b904ecb5f694e81c90740dd6223b0fbc77f1d0c1f75fa6003
container_end_page 156
container_issue 1
container_start_page 154
container_title Journal of the American College of Cardiology
container_volume 45
creator Kistler, Peter M.
Davidson, Neil C.
Sanders, Prashanthan
Fynn, Simon P.
Stevenson, Irene H.
Spence, Steven J.
Vohra, Jitendra K.
Sparks, Paul B.
Kalman, Jonathan M.
description In differing animal models, angiotensin-converting enzyme inhibition or angiotensin II (AII) antagonists has been shown to prevent both acute (hours) (2) electrical remodeling and chronic (weeks) structural remodeling (3). Clinical studies have suggested that AII antagonists or angiotensin-converting enzyme inhibitors may be effective in reducing AF in patients with heart failure or after cardioversion (10,11).
doi_str_mv 10.1016/j.jacc.2004.10.002
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67337449</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109704019321</els_id><sourcerecordid>3242535021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-d11571b0f6aaed25b904ecb5f694e81c90740dd6223b0fbc77f1d0c1f75fa6003</originalsourceid><addsrcrecordid>eNp9kEFr3DAQhUVoSbZp_0APxVDIzdsZ25Is6CWEplkItIf2LGR5lMh4ra1kF_bfV-4uFHrIaeDxvcfwMfYeYYuA4tOwHYy12wqgycEWoLpgG-S8LWuu5Cu2AVnzEkHJK_YmpQEARIvqkl0hF5WqW7Vh32-7RJOlIrjC2GWmgpwjO6e_wfTkw0xT8lOx2xVhKswcvRkLGjMSw-H5mHwYw9OxyMTzsjdTesteOzMmene-1-zn_Zcfdw_l47evu7vbx9I2TTuXPSKX2IETxlBf8U5BQ7bjTqiGWrQKZAN9L6qqzlBnpXTYg0UnuTMCoL5mN6fdQwy_Fkqz3vtkaRzNRGFJWsi6lk2jMvjxP3AIS5zybxo5COSZw0xVJ8rGkFIkpw_R7008agS92taDXm3r1faaZdu59OE8vXR76v9Vznoz8PkEUDbx21PUyfpVd-9jNqj74F_a_wP5EY_e</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1506153371</pqid></control><display><type>article</type><title>Absence of acute effects of angiotensin II on atrial electrophysiology in humans</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Kistler, Peter M. ; Davidson, Neil C. ; Sanders, Prashanthan ; Fynn, Simon P. ; Stevenson, Irene H. ; Spence, Steven J. ; Vohra, Jitendra K. ; Sparks, Paul B. ; Kalman, Jonathan M.</creator><creatorcontrib>Kistler, Peter M. ; Davidson, Neil C. ; Sanders, Prashanthan ; Fynn, Simon P. ; Stevenson, Irene H. ; Spence, Steven J. ; Vohra, Jitendra K. ; Sparks, Paul B. ; Kalman, Jonathan M.</creatorcontrib><description>In differing animal models, angiotensin-converting enzyme inhibition or angiotensin II (AII) antagonists has been shown to prevent both acute (hours) (2) electrical remodeling and chronic (weeks) structural remodeling (3). Clinical studies have suggested that AII antagonists or angiotensin-converting enzyme inhibitors may be effective in reducing AF in patients with heart failure or after cardioversion (10,11).</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2004.10.002</identifier><identifier>PMID: 15629389</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Angiotensin II - pharmacology ; Atrial Function - drug effects ; Atrial Function - physiology ; Cardiology ; Drug therapy ; Electrophysiologic Techniques, Cardiac ; Enzymes ; Female ; Heart Atria - drug effects ; Heart failure ; Hemodynamics - drug effects ; Humans ; Male ; Renin-Angiotensin System - physiology ; Vasoconstrictor Agents - pharmacology</subject><ispartof>Journal of the American College of Cardiology, 2005-01, Vol.45 (1), p.154-156</ispartof><rights>2005 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Jan 4, 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-d11571b0f6aaed25b904ecb5f694e81c90740dd6223b0fbc77f1d0c1f75fa6003</citedby><cites>FETCH-LOGICAL-c448t-d11571b0f6aaed25b904ecb5f694e81c90740dd6223b0fbc77f1d0c1f75fa6003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15629389$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kistler, Peter M.</creatorcontrib><creatorcontrib>Davidson, Neil C.</creatorcontrib><creatorcontrib>Sanders, Prashanthan</creatorcontrib><creatorcontrib>Fynn, Simon P.</creatorcontrib><creatorcontrib>Stevenson, Irene H.</creatorcontrib><creatorcontrib>Spence, Steven J.</creatorcontrib><creatorcontrib>Vohra, Jitendra K.</creatorcontrib><creatorcontrib>Sparks, Paul B.</creatorcontrib><creatorcontrib>Kalman, Jonathan M.</creatorcontrib><title>Absence of acute effects of angiotensin II on atrial electrophysiology in humans</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>In differing animal models, angiotensin-converting enzyme inhibition or angiotensin II (AII) antagonists has been shown to prevent both acute (hours) (2) electrical remodeling and chronic (weeks) structural remodeling (3). Clinical studies have suggested that AII antagonists or angiotensin-converting enzyme inhibitors may be effective in reducing AF in patients with heart failure or after cardioversion (10,11).</description><subject>Adult</subject><subject>Angiotensin II - pharmacology</subject><subject>Atrial Function - drug effects</subject><subject>Atrial Function - physiology</subject><subject>Cardiology</subject><subject>Drug therapy</subject><subject>Electrophysiologic Techniques, Cardiac</subject><subject>Enzymes</subject><subject>Female</subject><subject>Heart Atria - drug effects</subject><subject>Heart failure</subject><subject>Hemodynamics - drug effects</subject><subject>Humans</subject><subject>Male</subject><subject>Renin-Angiotensin System - physiology</subject><subject>Vasoconstrictor Agents - pharmacology</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9kEFr3DAQhUVoSbZp_0APxVDIzdsZ25Is6CWEplkItIf2LGR5lMh4ra1kF_bfV-4uFHrIaeDxvcfwMfYeYYuA4tOwHYy12wqgycEWoLpgG-S8LWuu5Cu2AVnzEkHJK_YmpQEARIvqkl0hF5WqW7Vh32-7RJOlIrjC2GWmgpwjO6e_wfTkw0xT8lOx2xVhKswcvRkLGjMSw-H5mHwYw9OxyMTzsjdTesteOzMmene-1-zn_Zcfdw_l47evu7vbx9I2TTuXPSKX2IETxlBf8U5BQ7bjTqiGWrQKZAN9L6qqzlBnpXTYg0UnuTMCoL5mN6fdQwy_Fkqz3vtkaRzNRGFJWsi6lk2jMvjxP3AIS5zybxo5COSZw0xVJ8rGkFIkpw_R7008agS92taDXm3r1faaZdu59OE8vXR76v9Vznoz8PkEUDbx21PUyfpVd-9jNqj74F_a_wP5EY_e</recordid><startdate>20050104</startdate><enddate>20050104</enddate><creator>Kistler, Peter M.</creator><creator>Davidson, Neil C.</creator><creator>Sanders, Prashanthan</creator><creator>Fynn, Simon P.</creator><creator>Stevenson, Irene H.</creator><creator>Spence, Steven J.</creator><creator>Vohra, Jitendra K.</creator><creator>Sparks, Paul B.</creator><creator>Kalman, Jonathan M.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20050104</creationdate><title>Absence of acute effects of angiotensin II on atrial electrophysiology in humans</title><author>Kistler, Peter M. ; Davidson, Neil C. ; Sanders, Prashanthan ; Fynn, Simon P. ; Stevenson, Irene H. ; Spence, Steven J. ; Vohra, Jitendra K. ; Sparks, Paul B. ; Kalman, Jonathan M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-d11571b0f6aaed25b904ecb5f694e81c90740dd6223b0fbc77f1d0c1f75fa6003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Angiotensin II - pharmacology</topic><topic>Atrial Function - drug effects</topic><topic>Atrial Function - physiology</topic><topic>Cardiology</topic><topic>Drug therapy</topic><topic>Electrophysiologic Techniques, Cardiac</topic><topic>Enzymes</topic><topic>Female</topic><topic>Heart Atria - drug effects</topic><topic>Heart failure</topic><topic>Hemodynamics - drug effects</topic><topic>Humans</topic><topic>Male</topic><topic>Renin-Angiotensin System - physiology</topic><topic>Vasoconstrictor Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kistler, Peter M.</creatorcontrib><creatorcontrib>Davidson, Neil C.</creatorcontrib><creatorcontrib>Sanders, Prashanthan</creatorcontrib><creatorcontrib>Fynn, Simon P.</creatorcontrib><creatorcontrib>Stevenson, Irene H.</creatorcontrib><creatorcontrib>Spence, Steven J.</creatorcontrib><creatorcontrib>Vohra, Jitendra K.</creatorcontrib><creatorcontrib>Sparks, Paul B.</creatorcontrib><creatorcontrib>Kalman, Jonathan M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kistler, Peter M.</au><au>Davidson, Neil C.</au><au>Sanders, Prashanthan</au><au>Fynn, Simon P.</au><au>Stevenson, Irene H.</au><au>Spence, Steven J.</au><au>Vohra, Jitendra K.</au><au>Sparks, Paul B.</au><au>Kalman, Jonathan M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Absence of acute effects of angiotensin II on atrial electrophysiology in humans</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2005-01-04</date><risdate>2005</risdate><volume>45</volume><issue>1</issue><spage>154</spage><epage>156</epage><pages>154-156</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>In differing animal models, angiotensin-converting enzyme inhibition or angiotensin II (AII) antagonists has been shown to prevent both acute (hours) (2) electrical remodeling and chronic (weeks) structural remodeling (3). Clinical studies have suggested that AII antagonists or angiotensin-converting enzyme inhibitors may be effective in reducing AF in patients with heart failure or after cardioversion (10,11).</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15629389</pmid><doi>10.1016/j.jacc.2004.10.002</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2005-01, Vol.45 (1), p.154-156
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_miscellaneous_67337449
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Adult
Angiotensin II - pharmacology
Atrial Function - drug effects
Atrial Function - physiology
Cardiology
Drug therapy
Electrophysiologic Techniques, Cardiac
Enzymes
Female
Heart Atria - drug effects
Heart failure
Hemodynamics - drug effects
Humans
Male
Renin-Angiotensin System - physiology
Vasoconstrictor Agents - pharmacology
title Absence of acute effects of angiotensin II on atrial electrophysiology in humans
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T15%3A38%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Absence%20of%20acute%20effects%20of%20angiotensin%20II%20on%20atrial%20electrophysiology%20in%20humans&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Kistler,%20Peter%20M.&rft.date=2005-01-04&rft.volume=45&rft.issue=1&rft.spage=154&rft.epage=156&rft.pages=154-156&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2004.10.002&rft_dat=%3Cproquest_cross%3E3242535021%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c448t-d11571b0f6aaed25b904ecb5f694e81c90740dd6223b0fbc77f1d0c1f75fa6003%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1506153371&rft_id=info:pmid/15629389&rfr_iscdi=true